AI In Inflammatory Bowel Disease Market
According to Intent Market Research, the Artificial Intelligence (AI) In Inflammatory Bowel Disease Market is expected to grow from USD 1.3 billion in 2023 at a CAGR of 44.5% to touch USD 17.0 billion by 2030. The Artificial Intelligence (AI) In Inflammatory Bowel Disease Market is dominated by key players such as AbbVie, AiCure, Bristol-Myers Squibb, CureMetrix, Fujifilm Holdings, GE Healthcare, Horizon Therapeutics, IBM Watson Health, IntelliHealth, Medtronic, Novartis, Siemens Healthineers and Zebra Medical Vision.